Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PMID: 14625346
The biotech could be in line for further cash if Novo chooses to expand the agreement to cover other metabolic or cardiovascular disease candidates, with milestone payments totaling $77.5 million attached to each one
Less gas, less discomfort
Market Overview The India GLP-1 Receptor Agonist Market is valued at USD 82.2 million in 2024 with an approximated compound annual growth rate (CAGR) of 24.6% from 2024-2030, based on a comprehensive analysis approved by leading health organizations and market research firms
Learn how this opioid antagonist works on the immune system and how your genetics can play a part in its efficacy
US$ 28.69
US$ 29.48
US$ 21.63
US$ 28.94
